136 related articles for article (PubMed ID: 31625183)
1. A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution.
Velier M; Granata A; Bramanti S; Calmels B; Furst S; Legrand F; Harbi S; Faucher C; Devillier R; Blaise D; Mfarrej B; Lemarie C; Chabannon C
Transfusion; 2019 Nov; 59(11):3442-3447. PubMed ID: 31625183
[TBL] [Abstract][Full Text] [Related]
2. Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old.
Motlló C; Sancho JM; Grífols JR; Juncà J; Morgades M; Ester A; Rodríguez I; Vives S; Batlle M; Guardia R; Ferrà C; Gallardo D; Millá F; Feliu E; Ribera JM
Cytotherapy; 2014 Mar; 16(3):406-11. PubMed ID: 24176544
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors.
Newell LF; Shoop KM; Knight RJ; Murray SN; Kwock RP; Jacoby CE; Slater S; Allen BE; Ottowa C; Cota B; Appel PL; Cook RJ; Maziarz RT; Meyers G
Cytotherapy; 2019 Jul; 21(7):725-737. PubMed ID: 31085121
[TBL] [Abstract][Full Text] [Related]
4. Fresh or Cryopreserved CD34
Ghobadi A; Fiala MA; Ramsingh G; Gao F; Abboud CN; Stockerl-Goldstein K; Uy GL; Grossman BJ; Westervelt P; DiPersio JF
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1072-1077. PubMed ID: 28323004
[TBL] [Abstract][Full Text] [Related]
5. Smoking is an important factor that affects peripheral blood progenitor cells yield in healthy male donors.
Zhen C; Fang X; Ding M; Wang X; Yuan D; Sui X; Liu X; Zhang L; Xu H; Li Y; Wang X
J Clin Apher; 2020 Jan; 35(1):33-40. PubMed ID: 31693224
[TBL] [Abstract][Full Text] [Related]
6. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
[TBL] [Abstract][Full Text] [Related]
7. Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.
Fraint E; Farooki S; Klein E; Mauguen A; Prockop SE; Scaradavou A; Curran K; Cancio M; Spitzer B; Boelens JJ; Oved J; Harris A; O'Reilly RJ; Kernan NA
Transplant Cell Ther; 2023 Jan; 29(1):46.e1-46.e6. PubMed ID: 36210027
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the CD34
Guo ZP; Wang T; Xu LP; Zhang XH; Wang Y; Huang XJ; Chang YJ
Transfus Apher Sci; 2016 Dec; 55(3):311-317. PubMed ID: 27665155
[TBL] [Abstract][Full Text] [Related]
9. Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.
De la Rubia J; Arbona C; Del Cañizo C; Arrieta R; De Arriba F; Pascual MJ; Sanjuan I; Díaz MA; Brunet S; Alegre A; Insunza A; Espigado I; Zamora C; De la Serna J; Serrano D; Bargay J; Petit J; Martínez D; Verdeguer A; Ribera JM; Martínez C; Benlloch L; Sanz MA
J Hematother Stem Cell Res; 2002 Aug; 11(4):705-9. PubMed ID: 12201959
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
11. Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantation.
Fiala MA; Park S; Slade M; DiPersio JF; Stockerl-Goldstein KE
Transfusion; 2016 Sep; 56(9):2331-5. PubMed ID: 27311884
[TBL] [Abstract][Full Text] [Related]
12. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
13. Gender, cholinesterase, platelet count and red cell count are main predictors of peripheral blood stem cell mobilization in healthy donors.
Fürst D; Hauber D; Reinhardt P; Schauwecker P; Bunjes D; Schulz A; Mytilineos J; Wiesneth M; Schrezenmeier H; Körper S
Vox Sang; 2019 Apr; 114(3):275-282. PubMed ID: 30873634
[TBL] [Abstract][Full Text] [Related]
14. The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.
de Greef GE; Braakman E; van der Holt B; Janssen JJWM; Petersen E; Vucinic V; Thuss N; Grootes M; Cornelissen JJ
Transfusion; 2019 Jan; 59(1):316-324. PubMed ID: 30548284
[TBL] [Abstract][Full Text] [Related]
15. Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34
Martino M; Gori M; Moscato T; Naso V; Ferreri A; Provenzano F; Loteta B; Sanguedolce MC; Console G; Dattola A; Pucci G; Gentile M; Morabito A; Recchia AG; Tripepi G; Pitino A
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1586-1591. PubMed ID: 31002994
[TBL] [Abstract][Full Text] [Related]
16. A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells.
Gordon PR; Leimig T; Mueller I; Babarin-Dorner A; Holladay MA; Houston J; Kerst G; Geiger T; Handgretinger R
Bone Marrow Transplant; 2002 Jul; 30(2):69-74. PubMed ID: 12132044
[TBL] [Abstract][Full Text] [Related]
17. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
[TBL] [Abstract][Full Text] [Related]
18. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for successful peripheral blood stem cell mobilization and collection in children.
Truong TH; Prokopishyn NL; Luu H; Guilcher GMT; Lewis VA
J Clin Apher; 2019 Oct; 34(5):598-606. PubMed ID: 31390093
[TBL] [Abstract][Full Text] [Related]
20. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device.
Schumm M; Lang P; Taylor G; Kuçi S; Klingebiel T; Bühring HJ; Geiselhart A; Niethammer D; Handgretinger R
J Hematother; 1999 Apr; 8(2):209-18. PubMed ID: 10349915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
